Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SPINE: Etanercept in Advanced Ankylosing Spondylitis
NCT00420238Phase 4Completed
- Sponsor
- Pfizer
- Start
- Jan 2007
- Primary completion
- Feb 2009
- Modality
- Fc-Fusion Proteins
- Countries
- 4
01
Overview
A Phase 4 trial of etanercept in ankylosing spondylitis (AS), sponsored by Pfizer. Started Jan 2007; status: completed.
02
Drugs
etanercept
03
Conditions
ankylosing spondylitis (AS)
Beyond the preview
Go deeper on NCT00420238.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00420238.